Vise Technologies Inc. Acquires Shares of 18,091 Cigna Group $CI

Vise Technologies Inc. bought a new position in shares of Cigna Group (NYSE:CIFree Report) during the second quarter, HoldingsChannel.com reports. The firm bought 18,091 shares of the health services provider’s stock, valued at approximately $4,987,000.

Other hedge funds also recently made changes to their positions in the company. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group in the fourth quarter valued at approximately $25,000. Cedar Mountain Advisors LLC increased its stake in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after acquiring an additional 68 shares during the period. Johnson Financial Group Inc. bought a new position in Cigna Group during the 2nd quarter worth $29,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group in the 4th quarter valued at $29,000. Finally, Prosperity Bancshares Inc acquired a new position in Cigna Group in the 4th quarter valued at $29,000. 86.99% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 2,677 shares of the business’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider owned 25,880 shares in the company, valued at $7,236,306.80. This represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 23,012 shares of company stock worth $6,386,550. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the topic of several analyst reports. Wells Fargo & Company increased their target price on Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Robert W. Baird set a $362.00 price target on Cigna Group in a research note on Friday, July 31st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. UBS Group raised their target price on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Finally, Wall Street Zen cut shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $339.45.

Get Our Latest Report on CI

Cigna Group Stock Down 1.1%

CI stock opened at $274.50 on Friday. The stock has a market capitalization of $72.53 billion, a P/E ratio of 11.36, a price-to-earnings-growth ratio of 0.95 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The firm has a 50-day moving average price of $284.63 and a 200-day moving average price of $281.41.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same period last year, the company posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s payout ratio is presently 25.82%.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.